BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $360,000 | -42.8% | 1,459,626 | +20.1% | 0.00% | 0.0% |
| Q2 2022 | $629,000 | -47.3% | 1,215,800 | +108.8% | 0.00% | 0.0% |
| Q1 2022 | $1,194,000 | -3.8% | 582,392 | +95.6% | 0.00% | -50.0% |
| Q4 2021 | $1,241,000 | +1577.0% | 297,709 | +1399.8% | 0.00% | – |
| Q1 2021 | $74,000 | – | 19,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |